Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record.

HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzyme

Open access
Miyata, Noriyuki, Taniguchi, Kazuo, Seki, Takayuki, Ishimoto, Tsuyoshi, Sato‐Watanabe, Mariko, Yasuda, Yoshiko, Doi, Mariko, Kametani, Shunichi, Tomishima, Yasumitsu, Ueki, Tomokazu, Sato, Masakazu, Kameo, Kazuya · 2001 · British Journal of Pharmacology

Abstract

The present study examined the inhibitory effects of N‐Hydroxy‐N′‐(4‐butyl‐2‐methylphenyl)‐formamidine (HET0016) on the renal metabolism of arachidonic acid by cytochrome P450 (CYP) enzymes. HET0016 exhibited a high degree of selectivity in inhibiting the formation of 20‐hydroxy‐5,8,11,14‐eicosatetraenoic acid (20‐HETE) in rat renal microsomes. The IC 50 value averaged 35±4 n M, whereas the IC 50 value for inhibition of the formation of epoxyeicosatrienoic acids by HET0016 averaged 2800±300 n M. In human renal microsomes, HET0016 potently inhibited the formation of 20‐HETE with an IC 50 value of 8.9±2.7 n M. Higher concentrations of HET0016 also inhibited the CYP2C9, CYP2D6 and CYP3A4‐catalysed substrates oxidation with IC 50 values of 3300, 83,900 and 71,000 n M. The IC 50 value for HET0016 on cyclo‐oxygenase activity was 2300 n M. These results indicate that HET0016 is a potent and selective inhibitor of CYP enzymes responsible for the formation of 20‐HETE in man and rat. British Journal of Pharmacology (2001) 133, 325–329; doi:10.1038/sj.bjp.0704101

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0704101

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 194

Metadata

Authors
Miyata, N., Taniguchi, K., Seki, T., Ishimoto, T., Sato‐Watanabe, M., Yasuda, Y., Doi, M., Kametani, S., Tomishima, Y., Ueki, T., Sato, M., & Kameo, K.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2001-06
Volume
133
Issue
3
Pages
325-329
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1995142464
Cited by
194
References
0
FWCI
3.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzyme. https://app.cochat.ai/papers/10.1038/sj.bjp.0704101
The paper
Miyata, N., Taniguchi, K., Seki, T., Ishimoto, T., Sato‐Watanabe, M., Yasuda, Y., Doi, M., Kametani, S., Tomishima, Y., Ueki, T., Sato, M., & Kameo, K. (2001). HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzyme. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0704101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.